Molecular and Cellular Mechanisms in Cancer
Molecular and Cellular Mechanisms in Cancer
批准号:
10687834
负责人:
ANDREI GOGA
金额:
$55.87万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
未结题
起止时间:
2004-09-01 至 2025-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
!
The objective of this training program is to provide post-doctoral fellows with didactic and research experience
in cellular and molecular aspects of cancer to prepare them for independent investigative careers in basic and
translational cancer research. The program forms the core of cancer biology training in the Helen Diller Family
Comprehensive Cancer Center (HDCCC) at the University of California, San Francisco (UCSF). The faculty,
who are all members of the HDCCC, consists of basic researchers, laboratory-based physician-scientists, and
more applied clinician-investigators who share common interests in the multifaceted fields of cellular, molecular
and structural biology applied to the understanding of mechanisms of cancer initiation, progression, diagnosis
and therapy. The areas of didactic and research training will expose trainees to a spectrum of approaches,
concepts and opportunities from altered gene and protein structure and expression, cancer microenvironment
and immunity, cell cycling and signaling to differentiation and development. The goal of this approach is to
further the understanding of cancer incidence and progression so that the trainees will have an appropriate
perspective to approaching basic cancer research as well as to address, prevention, biomarkers and
translation to patients. Post-doctoral trainees will join one of 37 research groups involved in studying these
basic mechanisms. To broaden their experience, the trainees will have secondary mentors and will be
encouraged to seek out collaborations with other research groups at UCSF or outside. Because of the
significance and need for training in Bioinformatics and Computational Biology for modern cancer research, we
have initiated a workshop for our trainees, taught by the Program faculty. Trainees will have access to all the
academic resources available at UCSF. In this way, trainees will be provided with an in-depth research
experience in an environment that covers the broad forefront of molecular and cellular dysregulation in cancer.
Seminar programs, research-in-progress discussions and journal clubs complement the research training.
Trainees must have a Ph.D. or equivalent degree in cell or molecular biology, genetics, biochemistry or an
applicable discipline, or an M.D. or M.D., Ph.D. The trainees will be selected on the basis of past
accomplishments and promise, course work, grades achieved, suitability for the research projects and a
commitment to a research career. Trainees will receive a stipend for an average of 2 years, but will be part of
the program throughout their training period of at least 3 years. The program will consist of 8 trainees,
complemented by the larger group of other trainees in the host laboratories to make a significant critical mass
of basic cancer researchers in the CCC. Upon completion of the program, it is anticipated that the trainees will
continue careers in basic and translational cancer research in academic institutions, governmental agencies or
the biotechnology industry.
期刊论文(59)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/onc.2017.165
发表时间:
2017-10-05
期刊:
Oncogene
影响因子:
8
作者:
[Shahi P, Wang CY, Chou J, Hagerling C, Gonzalez Velozo H, Ruderisch A, Yu Y, Lai MD, Werb Z]
通讯作者:
Werb Z
Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients.
临床癌症患者中阿卡特-盾复合体样基因特征的系统分析。
DOI:
10.3892/mco.2016.1094
发表时间:
2017-01
期刊:
Molecular and clinical oncology
影响因子:
1.2
作者:
[Wang CY, Shahi P, Huang JT, Phan NN, Sun Z, Lin YC, Lai MD, Werb Z]
通讯作者:
Werb Z
DOI:
10.1016/j.semcancer.2014.03.006
发表时间:
2015-06
期刊:
Seminars in cancer biology
影响因子:
14.5
作者:
[Song IY, Balmain A]
通讯作者:
Balmain A
DOI:
10.1016/j.ccr.2013.11.014
发表时间:
2013-12-09
期刊:
Cancer cell
影响因子:
50.3
作者:
[Rivera LB, Bergers G]
通讯作者:
Bergers G
DOI:
10.1016/j.jmb.2011.11.036
发表时间:
2012-01-27
期刊:
JOURNAL OF MOLECULAR BIOLOGY
影响因子:
5.6
作者:
[Schneider, Eric L., Lee, Melody S., Baharuddin, Aida, Goetz, David H., Farady, Christopher J., Ward, Mick, Wang, Cheng-I, Craik, Charles S.]
通讯作者:
Craik, Charles S.
共 36 条
Understanding CDK1 Function and Cancer Vulnerabilities
-
批准号:10736617
-
项目类别:
-
资助金额:$48.39万
-
财政年份:2023
-
负责人:ANDREI GOGA
-
依托单位:
Understanding breast cancer progression as a defect in the mechanics of tissue self-organization
-
批准号:10395995
-
项目类别:
-
资助金额:$56.62万
-
财政年份:2020
-
负责人:ANDREI GOGA
-
依托单位:
Understanding breast cancer progression as a defect in the mechanics of tissue self-organization
-
批准号:10613917
-
项目类别:
-
资助金额:$48.8万
-
财政年份:2020
-
负责人:ANDREI GOGA
-
依托单位:
A single cell assay for tissue activity
-
批准号:10831316
-
项目类别:
-
资助金额:$16.13万
-
财政年份:2020
-
负责人:ANDREI GOGA
-
依托单位:
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors
-
批准号:10194413
-
项目类别:
-
资助金额:$36.94万
-
财政年份:2018
-
负责人:ANDREI GOGA
-
依托单位:
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors
-
批准号:10436804
-
项目类别:
-
资助金额:$36.2万
-
财政年份:2018
-
负责人:ANDREI GOGA
-
依托单位:
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)
-
批准号:8676483
-
项目类别:
-
资助金额:$59.3万
-
财政年份:2012
-
负责人:ANDREI GOGA
-
依托单位:
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)
-
批准号:8384577
-
项目类别:
-
资助金额:$61.1万
-
财政年份:2012
-
负责人:ANDREI GOGA
-
依托单位:
In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)
-
批准号:8513950
-
项目类别:
-
资助金额:$57.36万
-
财政年份:2012
-
负责人:ANDREI GOGA
-
依托单位:
Targeting the MYC Oncogene with CDK Inhibitors
-
批准号:8641666
-
项目类别:
-
资助金额:$34.17万
-
财政年份:2010
-
负责人:ANDREI GOGA
-
依托单位:
Targeting the MYC Oncogene with CDK Inhibitors
-
批准号:7890072
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2010
-
负责人:ANDREI GOGA
-
依托单位:
Targeting the MYC Oncogene with CDK Inhibitors
-
批准号:8220841
-
项目类别:
-
资助金额:$36.19万
-
财政年份:2010
-
负责人:ANDREI GOGA
-
依托单位:
Targeting the MYC Oncogene with CDK Inhibitors
-
批准号:8458489
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2010
-
负责人:ANDREI GOGA
-
依托单位:
Targeting the MYC Oncogene with CDK Inhibitors
-
批准号:8063614
-
项目类别:
-
资助金额:$36.69万
-
财政年份:2010
-
负责人:ANDREI GOGA
-
依托单位:
CDK Inhibition in Cancer
-
批准号:7274257
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2005
-
负责人:ANDREI GOGA
-
依托单位:
CDK Inhibition in Cancer
-
批准号:6967425
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2005
-
负责人:ANDREI GOGA
-
依托单位:
CDK Inhibition in Cancer
-
批准号:7097472
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2005
-
负责人:ANDREI GOGA
-
依托单位:
CDK Inhibition in Cancer
-
批准号:7663857
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2005
-
负责人:ANDREI GOGA
-
依托单位:
CDK Inhibition in Cancer
-
批准号:7468349
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2005
-
负责人:ANDREI GOGA
-
依托单位:
Molecular and Cellular Mechanisms in Cancer
-
批准号:10021940
-
项目类别:
-
资助金额:$57.15万
-
财政年份:2004
-
负责人:ANDREI GOGA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
-
批准号:81300605
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:唐琳
-
依托单位:
Molecular Plant
-
批准号:31224801
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2012
-
负责人:黄健秋
-
依托单位:
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位:
Molecular Plant
-
批准号:31024802
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:陈晓亚
-
依托单位:
Cellular & Molecular Immunology
-
批准号:30824806
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:魏海明
-
依托单位: